CADONILIMAB

UNII:	6FYG1DS4NW
Formula:
Preferred Substance Name:	CADONILIMAB
GSRS Full Record:	6FYG1DS4NW i

2394841-59-7
AK104
AK-104
ANTI-PD1/ANTI-CTLA4 BISPECIFIC ANTIBODY AK104
CADONILIMAB [INN]
CADONILIMAB [USAN]
CADONILIMAB [WHO-DD]
IMMUNOGLOBULIN G1 (235-ALANINE,236-ALANINE,238-ALANINE), ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN-MUS MUSCULUS .GAMMA.1-CHAIN) FUSION PROTEIN WITH PEPTIDE LINKER (GGGS)4 FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4) (HUMAN-MUS MUSCULUS HEAVY CHAIN V-D-J REGION) FUSION PROTEIN WITH PEPTIDE LINKER (GGGS)4 FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4) (HUMAN-MUS MUSCULUS .KAPPA.-CHAIN V-J REGION), DISULFIDE WITH HUMAN-MUS MUSCULUS .KAPPA.-CHAIN, DIMER
PD-1 X CTLA-4 DUAL CHECKPOINT INHIBITOR AK104

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

CADONILIMAB

Synonyms and Mappings

Resources